This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Analysts report that the global life science analytics market (descriptive analytics, predictive analytics, prescriptive analytics) is expected to double in value by 2026 ($47B up from $23B in 2020), driven by the “increased prevalence of chronic diseases, technological advancements and rising demand for improved data standardization.”
CMS is proposing the adoption of the CoreQ: Short Stay Discharge (known as the “CoreQ: SS DC”) measure beginning with the fiscal year 2026. CMS is also proposing the adoption of the COVIDVaccine: Percent of Patients/Residents Who Are Up to Date (known as the “Patient/Resident COVID-19Vaccine”) measure beginning with the fiscal year 2026.
The Guidance indicates that drugs already discounted under the 340B Drug Pricing Program should be excluded from the Part B rebate calculation right away and from the Part D rebate calculation beginning in 2026. [4] 4] Social Security Act § 1847A(i)(2)(A); CMS Guidance – Part B Inflation Rebates at p. 11] See DOJ Press Release No.
CMS is also adopting the COVIDVaccine: Percent of Patients/Residents Who Are Up to Date (known as the “Patient/Resident COVID-19Vaccine”) measure beginning with the FY 2026. CMS also finalized an increase of the SNF QRP data completion thresholds for the MDS Data Items beginning with FY 2026.
COVID-19Vaccines. 47] The Act adds the COVID-19vaccine to the definition of excepted medical treatment to clarify that an individual will not be deemed to have revoked their religious benefits election by receiving a COVID-19vaccine. [48]. if appropriate. [44]
For 2023 the healthcare cost growth benchmark is 3.5%, for 2024 3.2%, for 2025 3%, for 2026 2.8%, for 2027 2.8%. Below are the most recent health care related regulatory developments as published in the New Jersey Register in February 2022: On February 7, 2022, at 54 N.J.R. 199(b), the Office of the Governor restated Executive Order No.
Luke’s receives $1.5 Tennessee hospital names chief medical officer TEXAS $475M Hospital Headed to South San Antonio A case for acing the basics, per Christus’ chief clinical officer Another Texas hospital shutters: What ASCs need to know Hunt Regional Healthcare acquires two urgent care facilities in Rockwall County St.
Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’
fraud scheme Nursing home must face vaccine-related wrongful firing claim, but not $2M retaliation accusations Transgender woman sues employer, Harvard Pilgrim for discrimination MICHIGAN 48-unit senior housing development could go up next to Vicksburg Halls in Marysville Can ads help a Michigan nursing home fix a staffing crisis?
Vincent sued over COVID-19vaccine religious exemption process. COVID Infection Data In Maryland Could Be Skewed By At-Home Test Kits, Expert Says. Maryland Department of Health releases the 2022-2026 State Plan to Address Alzheimer’s Disease and Related Dementias. Ascension St. MASSACHUSETTS.
NATIONAL After decline, private equity investment in healthcare reaches turning point: PitchBook Agencies issue update on BlackSuit ransomware group Amazon diving deeper into healthcare AI CMS ups ante on nursing home fines Cost report prompts tweaks to ACO REACH model Federal court sets date for EMTALA oral argument hearing in Idaho-based case Federal (..)
NATIONAL After decline, private equity investment in healthcare reaches turning point: PitchBook Agencies issue update on BlackSuit ransomware group Amazon diving deeper into healthcare AI CMS ups ante on nursing home fines Cost report prompts tweaks to ACO REACH model Federal court sets date for EMTALA oral argument hearing in Idaho-based case Federal (..)
We organize all of the trending information in your field so you don't have to. Join 26,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content